Expanding the reach of commercial cell therapies requires changes at medical centers by David F. Stroncek, Nan Zhang, Jiaqiang Ren, Rob Somerville, Anh Dinh

Subjects: Get full text

The need for uniform and coordinated practices involving centrally manufactured cell therapies by David Stroncek, Anh Dinh, Herleen Rai, Nan Zhang, Rob Somerville, Sandhya Panch

Subjects: Get full text

Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions by Francesca Romana Mariotti, Linda Quatrini, Enrico Munari, Paola Vacca, Lorenzo Moretta

Subjects: Get full text

Erzhi pills reverse PD-L1-mediated immunosuppression in melanoma microenvironment by Zhirui Fang, Yuejin Xue, Yuze Leng, Lusha Zhang, Xiuyun Ren, Ning Yang, Jing Chen, Lu Chen, Hong Wang

Subjects: Get full text

Positioning SUMO as an immunological facilitator of oncolytic viruses for high-grade glioma by Paramesh V. Karandikar, Paramesh V. Karandikar, Lyle Suh, Jakob V. E. Gerstl, Sarah E. Blitz, Qing Rui Qu, Sae-Yeon Won, Florian A. Gessler, Omar Arnaout, Timothy R. Smith, Pier Paolo Peruzzi, Wei Yang, Gregory K. Friedman, Joshua D. Bernstock, Joshua D. Bernstock

Subjects: Get full text

Editorial: Cancer immunotherapies for hematologic malignancies - NK/CIK/CAR-T perspective by Amit Sharma, Amit Sharma, Antonio Rosato, Ingo G. H. Schmidt-Wolf

Subjects: “…cancer immunotherapies…”
Get full text

In situ immunomodulation of tumors with biosynthetic bacteria promote anti-tumor immunity by Zhongda Lin, Fanqiang Meng, Yumeng Ma, Chi Zhang, Zhirang Zhang, Zhaoxin Yang, Yuan Li, Linlin Hou, Yuzhong Xu, Xin Liang, Xudong Zhang

Subjects: Get full text

Editorial: Decoding checkpoint inhibitor-induced endocrinopathies by Deborah L. Burnett, Deborah L. Burnett, Megan B. Barnet, Megan B. Barnet, Megan B. Barnet, Katherine Samaras, Katherine Samaras, Katherine Samaras

Subjects: Get full text

Targeting Hypoxia-A2A Adenosinergic Immunosuppression of Antitumor T Cells During Cancer Immunotherapy by Joseph M. Steingold, Stephen M. Hatfield

Subjects: Get full text

Editorial: Personalized immunotherapy for cancer by Anna Pasetto, Anna Pasetto, Yong-Chen Lu

Subjects: “…cancer immunotherapies…”
Get full text

IL-21 augments rapamycin in expansion of alpha fetoprotein antigen specific stem-cell-like memory T cells in vitro by Victor Tunje Jeza, Xiaoyi Li, Jun Chen, Zhihui Liang, Aggrey Onago Adem, Xiongwen Wu

Subjects: Get full text

Bioinformatic-based genetic characterizations of neural regulation in skin cutaneous melanoma by Fengdi Wang, Fanjun Cheng, Fang Zheng

Subjects: Get full text

Revisiting T Cell Tolerance as a Checkpoint Target for Cancer Immunotherapy by Simone Nüssing, Simone Nüssing, Joseph A. Trapani, Joseph A. Trapani, Ian A. Parish, Ian A. Parish

Subjects: “…cancer immunotherapies…”
Get full text

mRNA‐based Vaccines Targeting the T‐cell Epitope‐rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti‐Tumor Immunity in Mice by Ge‐Xin Zhao, Guo‐Long Bu, Gang‐Feng Liu, Xiang‐Wei Kong, Cong Sun, Zi‐Qian Li, Dan‐Ling Dai, Hai‐Xia Sun, Yin‐Feng Kang, Guo‐Kai Feng, Qian Zhong, Mu‐Sheng Zeng

Subjects: “…cancer immunotherapies…”
Get full text

Development and characterization of a novel human CD137 agonistic antibody with anti‐tumor activity and a good safety profile in non‐human primates by Yingying Gao, Teddy Yang, Hu Liu, Ningning Song, Chaohui Dai, Yu Ding

Subjects: Get full text

Circulating tumor DNA: Opportunities and challenges for pharmacometric approaches by Benjamin Ribba, Andreas Roller, Hans-Joachim Helms, Martin Stern, Conrad Bleul

Subjects: Get full text

Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies by Yongchao Wang, Jinjin Wang, Dandan Zhu, Yufei Wang, Guangchao Qing, Yuxuan Zhang, Xiaoxuan Liu, Xing-Jie Liang

Subjects: “…Nanoparticle-based cancer immunotherapies…”
Get full text

Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion by Ankita Mitra, Anoop Kumar, Nitin P. Amdare, Rajiv Pathak

Subjects: “…cancer immunotherapies…”
Get full text

An injectable gambogic acid loaded nanocomposite hydrogel enhances antitumor effect by reshaping immunosuppressive tumor microenvironment by Dan Lei, Wanru Wang, Jianhang Zhao, Yingling Zhou, Ying Chen, Juanjuan Dai, Yuling Qiu, Haoyue Qi, Chunhua Li, Boyao Liang, Baorui Liu, Qin Wang, Rutian Li

Subjects: “…Cancer immunotherapies…”
Get full text

Developing combination therapy to improve viral vector cancer vaccine efficacy by Noblecourt, L

Subjects: “…Cancer--Immunotherapy…”